AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Immunoglobulins Market Drivers, Restraints & Opportunities During the Forecast Period, 2018-2026 - ResearchAndMarkets.com

January 6, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 6, 2020--

The  “Immunoglobulins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026”  report has been added to  ResearchAndMarkets.com’s  offering.

Global Immunoglobulins Market: Overview

This report analyzes the current and future scenario of the global immunoglobulins market for the period 2018 to 2026. Rise in neurology, immunology, hematology, and other disease prevalence, high unmet medical needs, and rich pipeline are likely to be major drivers of the global immunoglobulins market during the forecast period.

The global immunoglobulins market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on applications, route of administration, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global immunoglobulins market.

Global Immunoglobulins Market: Key Segments

Based on application, the global immunoglobulins market has been segmented into neurology, immunology, hematology, and others. The segments have been analyzed based on available products used during the treatment of chronic diseases, and cost-effectiveness. In terms of route of administration, the global immunoglobulins market has been classified into intravenous, subcutaneous, and intramuscular. Based on end-user, the global immunoglobulins market has been divided into hospital, clinics, and homecare. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Immunoglobulins Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Immunoglobulins Market Analysis and Forecast, 2016-2026

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Disease Prevalence & Incidence Rate Globally with Key Countries

5.2. Regulatory Scenario by Region/globally

5.3. Pipeline Analysis

6. Global Immunoglobulins Market Analysis and Forecast, by Applications

6.1. Introduction & Definition

6.2. Key Findings/Developments

6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016-2026

6.3.1. Neurology

6.3.2. Immunology

6.3.3. Hematology

6.3.4. Others

6.4. Global Immunoglobulins Market Attractiveness by Applications

7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings/Developments

7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016-2026

7.3.1. Intravenous

7.3.2. Subcutaneous

7.3.3. Intramuscular

7.4. Global Immunoglobulins Market Attractiveness by Route of Administration

8. Global Immunoglobulins Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings/Developments

8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016-2026

8.3.1. Hospital

8.3.2. Clinic

8.3.3. Homecare

8.4. Global Immunoglobulins Market Attractiveness by End-user

9. Global Immunoglobulins Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Immunoglobulins Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Immunoglobulins Market Attractiveness, by Country/Region

10. North America Immunoglobulins Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2016-2026

10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2016-2026

10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2016-2026

10.5 North America Immunoglobulins Market Value Forecast, by Country, 2016-2026

10.6. North America Immunoglobulins Market Attractiveness Analysis

11. Europe Immunoglobulins Market Analysis and Forecast

12. Asia Pacific Immunoglobulins Market Analysis and Forecast

13. Latin America Immunoglobulins Market Analysis and Forecast

14. Middle East & Africa Immunoglobulins Market Analysis and Forecast

15. Competition Landscape

15.1. Market Player - Competition Matrix (by Tier and Size of companies)

15.2. Market Share Analysis by Company (2016)

15.3. Company Profiles

15.3.1. Shire

15.3.2. CSL Behring

15.3.3. Kedrion Biopharma Inc

15.3.4. Grifols, S.A.

15.3.5. Octapharma

15.3.6. China Biologic Products Holdings, Inc

15.3.7. Biotest AG

15.3.8. Sanquin

15.3.9. LFB SA

For more information about this report visit  https://www.researchandmarkets.com/r/n9t244

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

View source version on businesswire.com:https://www.businesswire.com/news/home/20200106005574/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/06/2020 08:46 AM/DISC: 01/06/2020 08:46 AM

http://www.businesswire.com/news/home/20200106005574/en